News
Pfizer gets BREAKTHROUGH THERAPY designation from FDA for patients suffering with ATOPIC DERMATITIS
Pfizer Inc. (NYSE:PFE) today announced its once-daily oral Janus kinase 1 (JAK1) inhibitor PF-04965842 received Breakthrough Therapy designation from the U.S. Food and Drug...
News
Pfizer invests $147M investment in portage
The world's largest pharmaceutical manufacturing plant is now 98,500 square feet larger.And that expansion -- the most visible part of an ongoing $147 million...
News
Apple, Intel, Merck, Pfizer, GE are Pimco’s Big buys
Pimco is the largest bond investor, but it also manages quite a bit in equities. According to S&P Capital IQ, Pimco now oversees $5.1...
News
Merck and Pfizer undergo failure in lung cancer trial
Merck KGaA and Pfizer received a setback on Thursday for their drug Bavencio, which is a late starter in the rapidly evolving field of...
Press Releases
FDA Approves Symdeko
Vertex Pharmaceuticals Incorporated announced that the U.S. FDA approved Symdeko (tezacaftor/ivacaftor and ivacaftor) for treating the underlying cause of cystic fibrosis (CF) in people...
Press Releases
FDA Approves Erleada
The U.S. FDA approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow...
Clinical Trials
Indian Government to come out with a new pharma policy
The government is looking to bring in a new pharma policy for implementing the proposed healthcare plan across the country in the next couple...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read